Oncolytic measles viruses to support BiTE and CAR T cell re-direction immunotherapies of solid tumors
- Alternative title
-
Onkolytische Masernviren zur Unterstützung von BiTE- und CAR-T-Zell-Immuntherapien solider Tumoren
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Heidelberg, Universität Heidelberg, Dissertation, 2019
- Keyword
-
Viruses
Measles
Tumors
- Event
-
Veröffentlichung
- (where)
-
Heidelberg
- (who)
-
Universitätsbibliothek Heidelberg
- (when)
-
2019
- Creator
- Contributor
- DOI
-
10.11588/heidok.00026650
- URN
-
urn:nbn:de:bsz:16-heidok-266506
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:55 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Heidbüchel, Johannes P. W.
- Bartenschlager, Ralf
- Universitätsbibliothek Heidelberg
Time of origin
- 2019
Other Objects (12)
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Key parameters of measles virus production for oncolytic virotherapy
Chemovirotherapy employing Gemcitabine together with Oncolytic Measles Vaccine Viruses as a new Option for the Treatment of Pancreatic Cancer
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Measles virus as vaccine platform against highly pathogenic emerging viruses
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Key parameters of measles virus production for oncolytic virotherapy
Chemovirotherapy employing Gemcitabine together with Oncolytic Measles Vaccine Viruses as a new Option for the Treatment of Pancreatic Cancer
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma
Measles virus as vaccine platform against highly pathogenic emerging viruses
Engineering targeted and cytokine-armed oncolytic measles viruses
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
BiTE-armed oncolytic measles viruses for cancer immunovirotherapy
Versatility of DARPin-targeted oncolytic measles viruses : safety, efficacy, and specificity
Oncolytic Virotherapy of Neuroendocrine Neoplasms with oncolytic measles vaccine virus
Combined application of oncolytic vaccinia and measles vaccine viruses for the treatment of highly resistant human tumor cells
Key parameters of measles virus production for oncolytic virotherapy
Chemovirotherapy employing Gemcitabine together with Oncolytic Measles Vaccine Viruses as a new Option for the Treatment of Pancreatic Cancer
Analysis of primary resistance phenomena to oncolytic measles vaccine virus
MicroRNA-mediated multi-tissue detargeting of oncolytic measles virus
Armed oncolytic measles vaccine virus for the treatment of hepatocellular carcinoma